Related Experiment Video
Updated: Jul 14, 2025

07:59
Folding and Characterization of a Bio-responsive Robot from DNA Origami
Published on: December 3, 2015
14.6K
Multivalent insulin receptor activation using insulin-DNA origami nanostructures
Joel Spratt1, José M Dias1,2, Christina Kolonelou1
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Nature Nanotechnology
|October 9, 2023
Summary
Researchers engineered insulin nanostructures to control receptor activation, improving diabetes treatment. This novel approach enhances insulin receptor (IR) signaling and glucose reduction in vivo.
Area of Science:
- Biochemistry
- Nanotechnology
- Molecular Biology
Background:
- Insulin receptor (IR) signaling is crucial for metabolic processes.
- Dysfunctional IR signaling is linked to diseases like diabetes, cancer, and neurodegenerative disorders.
- IRs can form nanoclusters on cell membranes, suggesting a role for spatial organization.
Purpose of the Study:
- To investigate how nanoscale spatial organization and multivalency of insulin affect IR activation.
- To develop novel insulin delivery systems with controlled nanoscale properties.
- To explore the therapeutic potential of precisely organized insulin for diabetes treatment.
Main Methods:
- Development of rod-like insulin-DNA origami nanostructures with varying insulin numbers and spacings.
- Assessment of insulin-DNA nanostructure residence time and IR activation levels in adipocytes.
- Evaluation of insulin-mediated transcriptional responses.
- Testing the efficacy of monovalent and multivalent insulin nanostructures in a zebrafish diabetes model.
Main Results:
- Increasing insulin valency on nanostructures significantly prolonged their residence time at IRs.
- Both insulin valency and spacing on nanostructures modulated IR activation levels in adipocytes.
- Multivalent insulin nanostructures demonstrated enhanced insulin-mediated transcriptional responses compared to monovalent ones.
- In vivo, multivalent insulin nanostructures effectively reduced glucose levels in a zebrafish diabetes model.
Conclusions:
- Precise control over insulin multivalency and nanoscale organization can modulate IR responses independently of concentration.
- Insulin nanoscale organization is a promising design parameter for developing advanced insulin therapies.
- This approach offers a new strategy for treating diseases associated with impaired IR signaling.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Recombinant DNA
95.6K
Overview
95.6K
Insulin: Biosynthesis, Chemistry, and Preparation
395
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
395
Cooperative Binding of Transcription Regulators
6.5K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.5K

